Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.LFWD · Entity 7620 | Director · President & CEO | March 25, 2026 | March 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date March 25, 2026 · Filed March 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.53 · Expires 2036-03-25 | Direct | 172,698 |
Reported balance
After 2026-03-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-25 · Grant · Acquired 172,698 · Balance 172,698 F1: The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. . |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. .
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2026 Filed Mar 27, 2026 20:57 UTC | Lifeward Ltd. LFWD · Entity 7620 | GrantOption (Right to Buy) · Derivative | 172,698 | $0.00 Strike: $6.53 | $0.00 |
DisclosureSEC source: 0001178913-26-001818 · ownership.xml · derivative · entry 1 Grant William Mark · CIK 0002071226 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,698 Underlying: Ordinary Shares, no par value per share · 172,698 shares Expires 2036-03-25 F1 · derivative.exercise_date: The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. . Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 21:54 UTC | Lifeward Ltd. LFWD · Entity 7620 | GrantOption (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-25-011025 · form4.xml · derivative · entry 1 Grant William Mark · CIK 0002071226 · President & Co-CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Ordinary Shares, par value NIS 1.75 per share · 400,000 shares Expires 2035-06-02 F1 · derivative.exercise_date: The shares underlying this option shall vest in four equal annual installments beginning on June 2, 2026, subject to the Reporting Person's continued service as of each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.